Both in Pharmaceuticals
Citius Oncology vs Xilio Therapeutics
Over the past year CTOR returned −65.2% and XLO returned −22.4%; their daily moves had a correlation of -0.07.
CTOR −65.2% XLO −22.4%Growth of $1, one year, split-adjusted
| Metric | CTOR | XLO |
|---|---|---|
| Price | $0.5470 | $8.71 |
| Market cap | $57.9M | $57.3M |
| Today | −0.55% | +0.35% |
| 1 month | −35.6% | −3.2% |
| 6 months | −39.8% | +10.3% |
| Year to date | −45.3% | −2.8% |
| 1 year | −67.2% | −26.8% |
| Revenue growth (YoY) | — | +131.2% |
| Gross margin | 67.1% | 100.0% |
| Net margin | −597.4% | −34.1% |
| P/E (TTM) | — | — |
| Price / sales | 8.1× | 0.9× |
| Net cash | $10.2M | $136.0M |
| Dividend yield | — | — |
| Volatility (60d) | 98.9% | 38.3% |
| Short % of float | 0.8% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).